Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Cardiac Troponin Market: By Type: Troponin T, Troponin I; By Site of Testing: Laboratory Testing, Point-of-care Testing; By Application; By End-Use; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Cardiac Troponin Market Outlook

The global cardiac troponin market is expected to grow at a CAGR of about 8.00% in the forecast period of 2022-2027, driven by the rising cases of heart failure.

 

North America to be a Significant Regional Market for Cardiac Troponin

North America is anticipated to dominate the global cardiac troponin industry in the forecast period. Heart failure is a critical healthcare issue in the United States. It is highly prevalent and has high mortality and morbidity rate. The cost of care for heart diseases is high in the United States. The prevalence of heart failure in the country is expected to increase with an increasingly ageing population, driving the market growth in the region.

The market is also growing due to high expenditure on research and development, major players and their product availability, and the well-established healthcare infrastructure in the region. The increase aids the demand for cardiac biomarkers for cardiovascular disease diagnosis, a rise in the incidence of the acute coronary syndrome (ACS), advancements in the treatment, and growth in demand for point-of-care cardiac testing kits. The key market players' high specificity and sensitivity of these markers to detect cardiac disorders also contribute to the market growth.

 

Market Segmentations

Troponin, a key regulatory protein of striated muscle's thin filament (actin), comprises three subunits: C, T, and I. Cardiovascular troponins are biomarkers or diagnostic markers used to detect myocardial infarction. Cardiac troponin is found in both skeletal and cardiac muscles, and a rise in cardiac troponin levels in the blood indicates the onset of myocardial infarction.

By type, the market includes:

  • Troponin T
  • Troponin I

Based on the site of testing, the market is divided into:

  • Laboratory Testing
  • Point-of-care Testing

The major applications of the market are:

  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Congestive Heart Failure
  • Others

The end-uses of the market include:

  • Hospitals
  • Diagnostic Centres
  • Homecare Settings
  • Others

The several distribution channels of the market are:

  • Manufacturer/ Distributor/ Service Provider
  • Aftermarket

The regional markets for the cardiac troponin industry can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

Rising Demand for Cardiac Biomarkers to Diagnose Cardiovascular Diseases Augmenting the Market Growth

The global cardiac troponin industry is driven by the rising demand for cardiac biomarkers to diagnose cardiovascular diseases, the increasing prevalence of acute coronary syndrome, and the reduction in the burden of healthcare costs due to faster and acute diagnosis. Patients suffering from acute critical heart conditions require immediate results and quick diagnosis to avoid any causalities. Hence, physicians and doctors demand advanced use of cardiac troponins, pushing researchers and major companies to make investments. Major companies are focusing on the research and development of cardiac troponin tests and are aiming for the approval of new products to retain and enhance market competitiveness. For instance, in June 2018, Beckman Coulter Diagnostics received Health Canada clearance for its new high sensitivity troponin (hsTnI) assay, Access hsTnI, that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms.

Besides this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. An increase in the geriatric population and a rise in the number of patients suffering from heart attacks and chest pain due to lifestyle changes are expected to drive the market in the coming years.

 

Key Players in the Global Cardiac Troponin Market

The report gives a detailed analysis of the following key players in the global cardiac troponin industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • Eurolyser Diagnostica GmbH
  • Beckman Coulter, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions   
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Region
7    Industry Opportunities and Challenges  
8    Global Cardiac Troponin Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Cardiac Troponin Historical Market (2017-2021) 
    8.3    Global Cardiac Troponin Market Forecast (2022-2027)
    8.4    Global Cardiac Troponin Market by Type
        8.4.1    Troponin T
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Troponin I
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
    8.5    Global Cardiac Troponin Market by Site of Testing
        8.5.1    Laboratory Testing
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Point-of-care Testing
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Cardiac Troponin Market by Application
        8.6.1    Acute Coronary Syndrome
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Myocardial Infarction
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Congestive Heart Failure
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Others
    8.7    Global Cardiac Troponin Market by End-Use
        8.7.1    Hospitals
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Diagnostic Centres
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
        8.7.3    Homecare Settings
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2017-2021)
            8.7.3.3    Forecast Trend (2022-2027)
        8.7.4    Others
    8.8    Global Cardiac Troponin Market by Distribution Channel
        8.8.1    Manufacturer/ Distributor/ Service Provider
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2017-2021)
            8.8.1.3    Forecast Trend (2022-2027)
        8.8.2    Aftermarket
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2017-2021)
            8.8.2.3    Forecast Trend (2022-2027)
    8.9    Global Cardiac Troponin Market by Region
        8.9.1    Market Share
            8.9.1.1    North America
            8.9.1.2    Europe
            8.9.1.3    Asia Pacific
            8.9.1.4    Latin America
            8.9.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Abbott Laboratories
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    F. Hoffmann-La Roche Ltd
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Siemens Healthcare GmbH
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Eurolyser Diagnostica GmbH
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Beckman Coulter, Inc.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Cardiac Troponin Market: Key Industry Highlights, 2017 and 2027
2.    Global Cardiac Troponin Historical Market: Breakup by Type (USD Million), 2017-2021
3.    Global Cardiac Troponin Market Forecast: Breakup by Type (USD Million), 2022-2027
4.    Global Cardiac Troponin Historical Market: Breakup by Site of Testing (USD Million), 2017-2021
5.    Global Cardiac Troponin Market Forecast: Breakup by Site of Testing (USD Million), 2022-2027
6.    Global Cardiac Troponin Historical Market: Breakup by Application (USD Million), 2017-2021
7.    Global Cardiac Troponin Market Forecast: Breakup by Application (USD Million), 2022-2027
8.    Global Cardiac Troponin Historical Market: Breakup by End-Use (USD Million), 2017-2021
9.    Global Cardiac Troponin Market Forecast: Breakup by End-Use (USD Million), 2022-2027
10.    Global Cardiac Troponin Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
11.    Global Cardiac Troponin Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
12.    Global Cardiac Troponin Historical Market: Breakup by Region (USD Million), 2017-2021
13.    Global Cardiac Troponin Market Forecast: Breakup by Region (USD Million), 2022-2027
14.    North America Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2017-2021
15.    North America Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Europe Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Europe Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Asia Pacific Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Asia Pacific Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Latin America Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2017-2021
21.    Latin America Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2022-2027
22.    Middle East and Africa Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2017-2021
23.    Middle East and Africa Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2022-2027
24.    Global Cardiac Troponin Market Structure.

Key Questions Answered in the Report

The global cardiac troponin market will grow at a CAGR of 8.00% between 2022 and 2027.

The major drivers of the market include the reduction in the burden of healthcare costs, increasing investments, growing research and development activities, approval of new products, rising awareness among patients and healthcare providers, increase in the geriatric population, rise in the number of patients suffering from heart attacks and chest pain, and changes in lifestyles.

The rising demand for cardiac biomarkers to diagnose cardiovascular diseases and the increasing prevalence of acute coronary syndrome are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Troponin T and troponin I are the different types of cardiac troponins in the market.

Based on the testing site, the market is divided into laboratory testing and point-of-care testing.

The major applications of the market are acute coronary syndrome, myocardial infarction, and congestive heart failure, among others.

The end-uses of the market include hospitals, diagnostic centres, and homecare settings, among others.

The several distribution channels of the market are manufacturer/ distributor/ service provider and aftermarket.

The major players in the industry are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Eurolyser Diagnostica GmbH, and Beckman Coulter, Inc., among others.

Analyst Review

The global cardiac troponin market has been driven by the increasing prevalence of acute coronary syndrome in the historical period. Aided by the increasing investments and rising demand for cardiac biomarkers to diagnose cardiovascular diseases, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 8.00%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Troponin T and troponin I are the different types of cardiac troponins in the market. Based on the testing site, the market is divided into laboratory testing and point-of-care testing. The major applications of the market are acute coronary syndrome, myocardial infarction, and congestive heart failure, among others. The end-uses of the market include hospitals, diagnostic centres, and homecare settings, among others. The several distribution channels of the market are manufacturer/ distributor/ service provider and aftermarket. The major regional markets for cardiac troponin are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The key players in the cardiac troponin market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Eurolyser Diagnostica GmbH, and Beckman Coulter, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER